Cargando…
Evaluation of circulating cell free DNA in plasma as a biomarker of different thyroid diseases()
INTRODUCTION: Many studies have been done on proteomics, genomics, epigenetic, immunogenetics in many body fluids. Among these, circulating cell-free DNA (ccfDNA) entered the literature in 1948, but it has not been studied for many years due to technological deficiencies. Following recent advances,...
Autores principales: | Caglar, Ozge, Cilgin, Begum, Eroglu, Mustafa, Cayir, Akin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422580/ https://www.ncbi.nlm.nih.gov/pubmed/30826312 http://dx.doi.org/10.1016/j.bjorl.2018.12.008 |
Ejemplares similares
-
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
por: Kohler, Corina, et al.
Publicado: (2009) -
Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule
por: Çayır, Derya, et al.
Publicado: (2017) -
Circulating BRAF V600E Cell-Free DNA as a Biomarker
in the Management of Anaplastic Thyroid Carcinoma
por: Iyer, Priyanka C., et al.
Publicado: (2018) -
LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer
por: Nagai, Yuzo, et al.
Publicado: (2017) -
Plasma circulating cell-free mitochondrial DNA in depressive disorders
por: Fernström, Johan, et al.
Publicado: (2021)